id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0027-0016,FDA,FDA-2005-D-0027,"Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry and Food and Drug Administration Staff - Final Guidance",Other,Guidance,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2024-11-07T00:43:10Z,,1,0,09000064853d399e
FDA-2005-D-0027-0015,FDA,FDA-2005-D-0027,"Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry and Food and Drug Administration Staff; and Procedures for Handling Post-Approval Studies Imposed by Premarket Approval Application Order; Guidance for Industry and Food and Drug Administration Staff; Availability - Final Guidance",Notice,Notice of Availability,2022-10-07T04:00:00Z,2022,10,2022-10-07T04:00:00Z,,2022-10-07T19:13:39Z,2022-21832,0,0,09000064853d399d
FDA-2005-D-0027-0014,FDA,FDA-2005-D-0027,Procedures for Handling Post-Approval Studies Imposed by PMA Orders,Other,Guidance,2022-10-06T04:00:00Z,2022,10,2022-10-06T04:00:00Z,,2022-10-06T20:12:10Z,,0,0,09000064853c7767
FDA-2005-D-0027-0013,FDA,FDA-2005-D-0027,Procedures for Handling Post-Approval Studies Imposed by PMA Order,Other,Guidance,2022-10-06T04:00:00Z,2022,10,2022-10-06T04:00:00Z,,2024-11-06T23:35:55Z,,1,0,09000064845bf520
FDA-2005-D-0027-0005,FDA,FDA-2005-D-0027,"Procedures for Handling Post-Approval Studies Imposed by Premarket Approval Application Order;
Draft Guidance for Industry and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2021-05-27T04:00:00Z,2021,5,2021-05-27T04:00:00Z,2021-07-27T03:59:59Z,2021-07-31T01:00:46Z,2021-11216,0,0,0900006484b3caf3
FDA-2005-D-0027-0006,FDA,FDA-2005-D-0027,Procedures for Handling Post-Approval Studies Imposed by Premarket Approval Application Order; Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2021-05-27T04:00:00Z,2021,5,2021-05-27T04:00:00Z,,2022-10-07T16:39:13Z,,0,0,0900006484b3cd5b
FDA-2005-D-0027-0003,FDA,FDA-2005-D-0027,Guideline,Supporting & Related Material,GDL-Guidance,2006-12-21T05:00:00Z,2006,12,,,2008-04-11T23:46:25Z,,0,0,090000648043e842
FDA-2005-D-0027-0004,FDA,FDA-2005-D-0027,FDA,Notice,NAD-Notice of Availability of Data,2006-12-21T05:00:00Z,2006,12,2006-12-20T05:00:00Z,,2008-04-11T23:46:25Z,,0,0,090000648043e843
FDA-2005-D-0027-0002,FDA,FDA-2005-D-0027,Guidance,Supporting & Related Material,GDL-Guidance,2005-09-15T04:00:00Z,2005,9,,,2008-04-11T23:46:25Z,,0,0,090000648043e837
FDA-2005-D-0027-0001,FDA,FDA-2005-D-0027,FDA,Notice,NAD-Notice of Availability of Data,2005-09-15T04:00:00Z,2005,9,2005-09-14T04:00:00Z,2005-11-15T04:59:59Z,2008-04-11T23:46:25Z,,0,0,090000648043e834